Soligenix Inc (SNGX)
0.4045
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.3992
-0.01
(-1.31%)
After-Hours: 20:00
Soligenix Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2022 | -4.006 |
September 30, 2022 | 9.581 |
June 30, 2022 | 2.348 |
March 31, 2022 | 1.498 |
December 31, 2021 | 0.9192 |
September 30, 2021 | 0.654 |
June 30, 2021 | 0.6306 |
March 31, 2021 | 0.5914 |
December 31, 2020 | 2.747 |
September 30, 2020 | 0.0564 |
June 30, 2020 | 0.0693 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
Date | Value |
---|---|
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | -0.2846 |
December 31, 2015 | -15.99 |
September 30, 2015 | -0.6143 |
June 30, 2015 | -1.762 |
March 31, 2015 | -2.822 |
December 31, 2014 | -24.63 |
September 30, 2014 | -1.738 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | -4.679 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
June 30, 2011 | 0.00 |
March 31, 2011 | 0.00 |
December 31, 2010 | 0.00 |
September 30, 2010 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-4.006
Minimum
Dec 2022
9.581
Maximum
Sep 2022
1.006
Average
0.5914
Median
Mar 2021
Debt to Equity Ratio Benchmarks
Eagle Pharmaceuticals Inc | -- |
Marinus Pharmaceuticals Inc | 4.353 |
NovaBay Pharmaceuticals Inc | 0.3431 |
Palatin Technologies Inc | 0.00 |
iBio Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 9.797M |
Total Liabilities (Quarterly) | 7.275M |
Shareholders Equity (Quarterly) | 2.522M |